{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:56:52Z","timestamp":1793764612824,"version":"4.6.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enhancing the intracellular delivery and performance of RNA-guided CRISPR-Cas9 nucleases (RGNs) remains in demand. Here, we show that nuclear translocation of commonly used <jats:italic>Streptococcus pyogenes<\/jats:italic> Cas9 (SpCas9) proteins is suboptimal. Hence, we generated eCas9.4NLS by endowing the high-specificity eSpCas9(1.1) nuclease (eCas9.2NLS) with additional nuclear localization signals (NLSs). We demonstrate that eCas9.4NLS coupled to prototypic or optimized guide RNAs achieves efficient targeted DNA cleavage and probe the performance of SpCas9 proteins with different NLS compositions at target sequences embedded in heterochromatin versus euchromatin. Moreover, after adenoviral vector (AdV)-mediated transfer of SpCas9 expression units, unbiased quantitative immunofluorescence microscopy revealed 2.3-fold higher eCas9.4NLS nuclear enrichment levels than those observed for high-specificity eCas9.2NLS. This improved nuclear translocation yielded in turn robust gene editing after nonhomologous end joining repair of targeted double-stranded DNA breaks. In particular, AdV delivery of eCas9.4NLS into muscle progenitor cells resulted in significantly higher editing frequencies at defective <jats:italic>DMD<\/jats:italic> alleles causing Duchenne muscular dystrophy (DMD) than those achieved by AdVs encoding the parental, eCas9.2NLS, protein. In conclusion, this work provides a strong rationale for integrating viral vector and optimized gene-editing technologies to bring about enhanced RGN delivery and performance.<\/jats:p>","DOI":"10.1038\/s41434-019-0119-y","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T11:05:39Z","timestamp":1578049539000},"page":"209-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components"],"prefix":"10.1038","volume":"27","author":[{"given":"Ignazio","family":"Maggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidde A.","family":"Zittersteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Toral","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e8re M.","family":"van der Maarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9443-8377","authenticated-orcid":false,"given":"Rob C.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A. F. V.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"119_CR1","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096.","journal-title":"Science."},{"key":"119_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tibtech.2015.02.011","volume":"33","author":"I Maggio","year":"2015","unstructured":"Maggio I, Gon\u00e7alves MA. Genome editing at the crossroads of delivery, specificity, and fidelity. Trends Biotechnol. 2015;33:280\u201391.","journal-title":"Trends Biotechnol."},{"key":"119_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2017.09.007","volume":"68","author":"K Murugan","year":"2017","unstructured":"Murugan K, Babu K, Sundaresan R, Rajan R, Sashital DG. The revolution continues: newly discovered systems expand the CRISPR-Cas toolkit. Mol Cell. 2017;68:15\u201325.","journal-title":"Mol Cell."},{"key":"119_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.isci.2018.08.001","volume":"6","author":"X Chen","year":"2018","unstructured":"Chen X, Gon\u00e7alves MA. DNA, RNA, and protein tools for editing the genetic information in human cells. iScience. 2018;6:247\u201363.","journal-title":"iScience"},{"key":"119_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823\u20136.","journal-title":"Science."},{"key":"119_CR6","doi-asserted-by":"publisher","first-page":"e00471","DOI":"10.7554\/eLife.00471","volume":"2","author":"M Jinek","year":"2013","unstructured":"Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. RNA-programmed genome editing in human cells. Elife. 2013;2:e00471.","journal-title":"Elife."},{"key":"119_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339:819\u201323.","journal-title":"Science"},{"key":"119_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","volume":"156","author":"H Nishimasu","year":"2014","unstructured":"Nishimasu H, Ran FA, Hsu PD, Konermann S, Shehata SI, Dohmae N, et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell. 2014;156:935\u201349.","journal-title":"Cell."},{"key":"119_CR9","doi-asserted-by":"publisher","first-page":"1247997","DOI":"10.1126\/science.1247997","volume":"343","author":"M Jinek","year":"2014","unstructured":"Jinek M, Jiang F, Taylor DW, Sternberg SH, Kaya E, Ma E, et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science. 2014;343:1247997.","journal-title":"Science."},{"key":"119_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature13579","volume":"513","author":"C Anders","year":"2014","unstructured":"Anders C, Niewoehner O, Duerst A, Jinek M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature. 2014;513:569\u201373.","journal-title":"Nature."},{"key":"119_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816\u201321.","journal-title":"Science."},{"key":"119_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.molcel.2014.09.019","volume":"56","author":"AE Briner","year":"2014","unstructured":"Briner AE, Donohoue PD, Gomaa AA, Selle K, Slorach EM, Nye CH, et al. Guide RNA functional modules direct Cas9 activity and orthogonality. Mol Cell. 2014;56:333\u20139.","journal-title":"Mol Cell."},{"key":"119_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 2015;523:481\u20135.","journal-title":"Nature."},{"key":"119_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature. 2018;556:57\u201363.","journal-title":"Nature."},{"key":"119_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016;529:490\u20135.","journal-title":"Nature."},{"key":"119_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature24268","volume":"550","author":"JS Chen","year":"2017","unstructured":"Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature. 2017;550:407\u201310.","journal-title":"Nature."},{"key":"119_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2016","unstructured":"Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F, et al. Rationally engineered Cas9 nucleases with improved specificity. Science. 2016;351:84\u20138.","journal-title":"Science."},{"key":"119_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nbt.4066","volume":"36","author":"A Casini","year":"2018","unstructured":"Casini A, Olivieri M, Petris G, Montagna C, Reginato G, Maule G, et al. A highly specific SpCas9 variant is identified by in vivo screening in yeast. Nat Biotechnol. 2018;36:265\u201371.","journal-title":"Nat Biotechnol."},{"key":"119_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05477-x","volume":"9","author":"JK Lee","year":"2018","unstructured":"Lee JK, Jeong E, Lee J, Jung M, Shin E, Kim YH, et al. Directed evolution of CRISPR-Cas9 to increase its specificity. Nat Commun. 2018;9:3048.","journal-title":"Nat Commun."},{"key":"119_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.2808","volume":"32","author":"Y Fu","year":"2014","unstructured":"Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol. 2014;32:279\u201384.","journal-title":"Nat Biotechnol."},{"key":"119_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","volume":"155","author":"B Chen","year":"2013","unstructured":"Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li GW, et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system. Cell. 2013;155:1479\u201391. Erratum in: Cell. 2014;156:373","journal-title":"Cell"},{"key":"119_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0846-3","volume":"16","author":"Y Dang","year":"2015","unstructured":"Dang Y, Jia G, Choi J, Ma H, Anaya E, Ye C, et al. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency. Genome Biol. 2015;16:280.","journal-title":"Genome Biol."},{"key":"119_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tibtech.2017.11.006","volume":"36","author":"Z Glass","year":"2018","unstructured":"Glass Z, Lee M, Li Y, Xu Q. Engineering the delivery system for CRISPR-based genome editing. Trends Biotechnol. 2018;36:173\u201385.","journal-title":"Trends Biotechnol."},{"key":"119_CR24","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jmb.2015.10.023","volume":"428","author":"M Christie","year":"2016","unstructured":"Christie M, Chang CW, R\u00f3na G, Smith KM, Stewart AG, Takeda AA, et al. Structural biology and regulation of protein import into the nucleus. J Mol Biol. 2016;428:2060\u201390.","journal-title":"J Mol Biol"},{"key":"119_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/1061186X.2016.1184273","volume":"24","author":"Y Sun","year":"2016","unstructured":"Sun Y, Xian L, Xing H, Yu J, Yang Z, Yang T, et al. Factors influencing the nuclear targeting ability of nuclear localization signals. J Drug Target. 2016;24:927\u201333.","journal-title":"J Drug Target"},{"key":"119_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/rmv.494","volume":"16","author":"MA Gon\u00e7alves","year":"2006","unstructured":"Gon\u00e7alves MA, de Vries AA. Adenovirus: from foe to friend. Rev Med Virol. 2006;16:167\u201386.","journal-title":"Rev Med Virol"},{"key":"119_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/mt.2015.164","volume":"24","author":"X Chen","year":"2016","unstructured":"Chen X, Gon\u00e7alves MA. Engineered viruses as genome editing devices. Mol Ther. 2016;24:447\u201357.","journal-title":"Mol Ther."},{"key":"119_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep05105","volume":"4","author":"I Maggio","year":"2014","unstructured":"Maggio I, Holkers M, Liu J, Janssen JM, Chen X, Gon\u00e7alves MA. Adenoviral vector delivery of RNA-guided CRISPR\/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Sci Rep. 2014;4:5105.","journal-title":"Sci Rep."},{"key":"119_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/mt.2015.192","volume":"24","author":"L Xu","year":"2016","unstructured":"Xu L, Park KH, Zhao L, Xu J, El Refaey M, Gao Y, et al. CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice. Mol Ther. 2016;24:564\u20139.","journal-title":"Mol Ther."},{"key":"119_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep37051","volume":"6","author":"I Maggio","year":"2016","unstructured":"Maggio I, Liu J, Janssen JM, Chen X, Gon\u00e7alves MA. Adenoviral vectors encoding CRISPR\/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells. Sci Rep. 2016;6:37051.","journal-title":"Sci Rep."},{"key":"119_CR31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1126\/science.1237934","volume":"340","author":"S Nielsen","year":"2013","unstructured":"Nielsen S, Yuzenkova Y, Zenkin N. Mechanism of eukaryotic RNA polymerase III transcription termination. Science. 2013;340:1577\u201380.","journal-title":"Science."},{"key":"119_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/mt.2016.38","volume":"24","author":"EP Papapetrou","year":"2016","unstructured":"Papapetrou EP, Schambach A. Gene insertion into genomic safe harbors for human gene therapy. Mol Ther. 2016;24:678\u201384.","journal-title":"Mol Ther."},{"key":"119_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.virol.2004.01.007","volume":"321","author":"MA Gon\u00e7alves","year":"2004","unstructured":"Gon\u00e7alves MA, van der Velde I, Kna\u00e4n-Shanzer S, Valerio D, de Vries AA. Stable transduction of large DNA by high-capacity adeno-associated virus\/adenovirus hybrid vectors. Virology. 2004;321:287\u201396.","journal-title":"Virology."},{"key":"119_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.omtn.2017.08.005","volume":"8","author":"X Chen","year":"2017","unstructured":"Chen X, Liu J, Janssen JM, Gon\u00e7alves MA. The chromatin structure differentially impacts high-specificity CRISPR-Cas9 nuclease strategies. Mol Ther Nucleic Acids. 2017;8:558\u201363.","journal-title":"Mol Ther Nucleic Acids"},{"key":"119_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1325-9","volume":"18","author":"D Zhang","year":"2017","unstructured":"Zhang D, Zhang H, Li T, Chen K, Qiu JL, Gao C. Perfectly matched 20-nucleotide guide RNA sequences enable robust genome editing using high-fidelity SpCas9 nucleases. Genome Biol. 2017;18:191.","journal-title":"Genome Biol."},{"key":"119_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1355-3","volume":"18","author":"S Kim","year":"2017","unstructured":"Kim S, Bae T, Hwang J, Kim JS. Rescue of high-specificity Cas9 variants using sgRNAs with matched 5' nucleotides. Genome Biol. 2017;18:218.","journal-title":"Genome Biol."},{"key":"119_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00687-1","volume":"8","author":"X Chen","year":"2017","unstructured":"Chen X, Janssen JM, Liu J, Maggio I, \u2018t Jong AEJ, Mikkers HMM, et al. In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat Commun. 2017;8:657.","journal-title":"Nat Commun."},{"key":"119_CR38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nbt.2675","volume":"31","author":"P Mali","year":"2013","unstructured":"Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 2013;31:833\u20138.","journal-title":"Nat Biotechnol."},{"key":"119_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31:827\u201332.","journal-title":"Nat Biotechnol."},{"key":"119_CR40","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1093\/nar\/gkw524","volume":"44","author":"X Chen","year":"2016","unstructured":"Chen X, Rinsma M, Janssen JM, Liu J, Maggio I, Gon\u00e7alves MA. Probing the impact of chromatin conformation on genome editing tools. Nucleic Acids Res. 2016;44:6482\u201392.","journal-title":"Nucleic Acids Res"},{"key":"119_CR41","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nbt.2889","volume":"32","author":"X Wu","year":"2014","unstructured":"Wu X, Scott DA, Kriz AJ, Chiu AC, Hsu PD, Dadon DB, et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol. 2014;32:670\u20136.","journal-title":"Nat Biotechnol."},{"key":"119_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aac6572","volume":"350","author":"SC Knight","year":"2015","unstructured":"Knight SC, Xie L, Deng W, Guglielmi B, Witkowsky LB, Bosanac L, et al. Dynamics of CRISPR-Cas9 genome interrogation in living cells. Science. 2015;350:823\u20136.","journal-title":"Science."},{"key":"119_CR43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1021\/acssynbio.5b00299","volume":"6","author":"RM Daer","year":"2017","unstructured":"Daer RM, Cutts JP, Brafman DA, Haynes KA. The impact of chromatin dynamics on Cas9-mediated genome editing in human cells. ACS Synth Biol. 2017;6:428\u201338.","journal-title":"ACS Synth Biol"},{"key":"119_CR44","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/1873-3468.12707","volume":"591","author":"KT Jensen","year":"2017","unstructured":"Jensen KT, Fl\u00f8e L, Petersen TS, Huang J, Xu F, Bolund L, et al. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency. FEBS Lett. 2017;591:1892\u2013901.","journal-title":"FEBS Lett."},{"key":"119_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.omtn.2019.02.009","volume":"16","author":"JM Janssen","year":"2019","unstructured":"Janssen JM, Chen X, Liu J, Gon\u00e7alves MAFV. The chromatin structure of CRISPR-Cas9 target DNA controls the balance between mutagenic and homology-directed gene-editing events. Mol Ther Nucleic Acids. 2019;16:141\u201354.","journal-title":"Mol Ther Nucleic Acids"},{"key":"119_CR46","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/nar\/gkv1540","volume":"44","author":"I Maggio","year":"2016","unstructured":"Maggio I, Stefanucci L, Janssen JM, Liu J, Chen X, Mouly V, et al. Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations. Nucleic Acids Res. 2016;44:1449\u201370.","journal-title":"Nucleic Acids Res"},{"key":"119_CR47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt.4194","volume":"36","author":"MP Zafra","year":"2018","unstructured":"Zafra MP, Schatoff EM, Katti A, Foronda M, Breinig M, Schweitzer AY, et al. Optimized base editors enable efficient editing in cells, organoids and mice. Nat Biotechnol. 2018;36:888\u201393.","journal-title":"Nat Biotechnol."},{"key":"119_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/311033a0","volume":"311","author":"D Kalderon","year":"1984","unstructured":"Kalderon D, Richardson WD, Markham AF, Smith AE. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature. 1984;311:33\u20138.","journal-title":"Nature."},{"key":"119_CR49","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0092-8674(84)90457-4","volume":"39","author":"D Kalderon","year":"1984","unstructured":"Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear location. Cell. 1984;39:499\u2013509.","journal-title":"Cell."},{"key":"119_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0092-8674(82)90242-2","volume":"30","author":"C Dingwall","year":"1982","unstructured":"Dingwall C, Sharnick SV, Laskey RA. A polypeptide domain that specifies migration of nucleoplasmin into the nucleus. Cell. 1982;30:449\u201358.","journal-title":"Cell."},{"key":"119_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas CF 3rd. ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol. 2013;31:397\u2013405.","journal-title":"Trends Biotechnol."},{"key":"119_CR52","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1038\/mtna.2015.6","volume":"4","author":"J Liu","year":"2015","unstructured":"Liu J, Gaj T, Wallen MC, Barbas CF. Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids. 2015;4:e232.","journal-title":"Mol Ther Nucleic Acids"},{"key":"119_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2045-9769-2-5","volume":"2","author":"R Ru","year":"2013","unstructured":"Ru R, Yao Y, Yu S, Yin B, Xu W, Zhao S, et al. Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs. Cell Regen. 2013;2:5.","journal-title":"Cell Regen"},{"key":"119_CR54","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/nprot.2015.117","volume":"10","author":"J Liu","year":"2015","unstructured":"Liu J, Gaj T, Yang Y, Wang N, Shui S, Kim S, et al. Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells. Nat Protoc. 2015;10:1842\u201359.","journal-title":"Nat Protoc."},{"key":"119_CR55","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt.3806","volume":"35","author":"BT Staahl","year":"2017","unstructured":"Staahl BT, Benekareddy M, Coulon-Bainier C, Banfal AA, Floor SN, Sabo JK, et al. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat Biotechnol. 2017;35:431\u20134.","journal-title":"Nat Biotechnol."},{"key":"119_CR56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1534\/g3.117.300359","volume":"8","author":"P Hu","year":"2018","unstructured":"Hu P, Zhao X, Zhang Q, Li W, Zu Y. Comparison of various nuclear localization signal-fused Cas9 Proteins and Cas9 mRNA for genome editing in zebrafish. G3. 2018;8:823\u201331.","journal-title":"G3"},{"key":"119_CR57","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.stemcr.2017.04.014","volume":"8","author":"R Torres-Ruiz","year":"2017","unstructured":"Torres-Ruiz R, Martinez-Lage M, Martin MC, Garcia A, Bueno C, Casta\u00f1o J, Ramirez JC, et al. Efficient recreation of t(11;22) EWSR1-FLI1+ in human stem cells using CRISPR\/Cas9. Stem Cell Rep. 2017;8:1408\u201320.","journal-title":"Stem Cell Rep"},{"key":"119_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/bit.21757","volume":"100","author":"MJ Havenga","year":"2008","unstructured":"Havenga MJ, Holterman L, Melis I, Smits S, Kaspers J, Heemskerk E, et al. Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity. Biotechnol Bioeng. 2008;100:273\u201383.","journal-title":"Biotechnol Bioeng."},{"key":"119_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jgm.2687","volume":"15","author":"JM Janssen","year":"2013","unstructured":"Janssen JM, Liu J, Skokan J, Gon\u00e7alves MA, de Vries AA. Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells. J Gene Med. 2013;15:1\u201311.","journal-title":"J Gene Med"},{"key":"119_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ymeth.2014.02.017","volume":"69","author":"M Holkers","year":"2014","unstructured":"Holkers M, Cathomen T, Gon\u00e7alves MA. Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells. Methods. 2014;69:179\u201387.","journal-title":"Methods."},{"key":"119_CR61","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nbt1319","volume":"25","author":"JC Miller","year":"2007","unstructured":"Miller JC, Holmes MC, Wang J, Guschin DY, Lee YL, Rupniewski I, et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol. 2007;25:778\u201385.","journal-title":"Nat Biotechnol."}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0119-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:17Z","timestamp":1684617257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-019-0119-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1038\/s41434-019-0119-y","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}